Pregnancy outcome of Japanese patients with glucokinase-maturity-onset diabetes of the young
- PMID: 30897270
- PMCID: PMC6825925
- DOI: 10.1111/jdi.13046
Pregnancy outcome of Japanese patients with glucokinase-maturity-onset diabetes of the young
Abstract
Aims/introduction: Glucokinase-maturity-onset diabetes of the young (GCK-MODY; also known as MODY2) is a benign hyperglycemic condition, which generally does not require medical interventions. The only known exception is increased birthweight and related perinatal complications in unaffected offspring of affected women. As previous data were obtained mostly from white Europeans, the present study analyzed the pregnancy outcomes of Japanese women with GCK-MODY to better formulate the management plan for this population.
Materials and methods: The study participants were 34 GCK-MODY families whose members were diagnosed at Osaka City General Hospital during 2010-2017. A total of 53 pregnancies (40 from 23 affected women, 13 from 11 unaffected women) were retrospectively analyzed by chart review.
Results: Birthweights of unaffected offspring born to affected women were significantly greater as compared with those of affected offspring (P = 0.003). The risk of >4,000 g birthweight (16%), however, was lower as compared with that previously reported for white Europeans, and none of the offspring had complications related to large birthweight. Insulin treatment of the affected women resulted in a significant reduction in the birthweights of unaffected offspring. Perinatal complications including small-for-gestational age birthweight were found only in affected offspring born to insulin-treated women.
Conclusions: In Japanese GCK-MODY families, unaffected offspring born to affected women were heavier than affected offspring. However, insulin treatment of affected women might not be advisable because of the lower risk of macrosomic birth injury, and an increased risk of perinatal complications in affected offspring.
Keywords: Glucokinase; Maturity-onset diabetes of the young; Pregnancy.
© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Figures


Similar articles
-
Identification and management of GCK-MODY complicating pregnancy in Chinese patients with gestational diabetes.Mol Cell Biochem. 2022 May;477(5):1629-1643. doi: 10.1007/s11010-022-04374-8. Epub 2022 Feb 28. Mol Cell Biochem. 2022. PMID: 35229243
-
The Challenges of Treating Glucokinase MODY during Pregnancy: A Review of Maternal and Fetal Outcomes.Int J Environ Res Public Health. 2022 May 14;19(10):5980. doi: 10.3390/ijerph19105980. Int J Environ Res Public Health. 2022. PMID: 35627517 Free PMC article. Review.
-
Evaluation of pregnancy outcomes in women with GCK-MODY.Diabet Med. 2021 Jun;38(6):e14488. doi: 10.1111/dme.14488. Epub 2021 Jan 12. Diabet Med. 2021. PMID: 33277730
-
The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.Am J Obstet Gynecol. 2015 Aug;213(2):236.e1-7. doi: 10.1016/j.ajog.2015.04.037. Epub 2015 Apr 30. Am J Obstet Gynecol. 2015. PMID: 25935773
-
Clinical implications of the glucokinase impaired function - GCK MODY today.Physiol Res. 2020 Dec 22;69(6):995-1011. doi: 10.33549/physiolres.934487. Epub 2020 Nov 2. Physiol Res. 2020. PMID: 33129248 Free PMC article. Review.
Cited by
-
Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge.J Diabetes Investig. 2021 Nov;12(11):1944-1947. doi: 10.1111/jdi.13670. Epub 2021 Oct 3. J Diabetes Investig. 2021. PMID: 34529362 Free PMC article.
-
Identification and management of GCK-MODY complicating pregnancy in Chinese patients with gestational diabetes.Mol Cell Biochem. 2022 May;477(5):1629-1643. doi: 10.1007/s11010-022-04374-8. Epub 2022 Feb 28. Mol Cell Biochem. 2022. PMID: 35229243
-
Pregnancy and Neonatal Outcomes in Maturity-Onset Diabetes of the Young: A Systematic Review.Int J Mol Sci. 2025 Jun 24;26(13):6057. doi: 10.3390/ijms26136057. Int J Mol Sci. 2025. PMID: 40649834 Free PMC article. Review.
-
The Challenges of Treating Glucokinase MODY during Pregnancy: A Review of Maternal and Fetal Outcomes.Int J Environ Res Public Health. 2022 May 14;19(10):5980. doi: 10.3390/ijerph19105980. Int J Environ Res Public Health. 2022. PMID: 35627517 Free PMC article. Review.
-
Case 6-2020: A 34-Year-Old Woman with Hyperglycemia.N Engl J Med. 2020 Feb 20;382(8):745-753. doi: 10.1056/NEJMcpc1913475. N Engl J Med. 2020. PMID: 32074423 Free PMC article. No abstract available.
References
-
- Chakera AJ, Steele AM, Gloyn AL, et al Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care 2015; 38: 1383–1392. - PubMed
-
- Kawakita R, Hosokawa Y, Fujimaru R, et al Molecular and clinical characterization of glucokinase maturity‐onset diabetes of the young (GCK‐MODY) in Japanese patients. Diabet Med 2014; 31: 1357–1362. - PubMed
-
- Hattersley AT, Beards F, Ballantyne E, et al Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998; 19: 268–270. - PubMed
-
- Bacon S, Schmid J, McCarthy A, et al The clinical management of hyperglycemia in pregnancy complicated by maturity‐onset diabetes of the young. Am J Obstet Gynecol 2015; 213: e1–e7. - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous